Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TXNRD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOC101928916 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OGG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
PTPRS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C7orf26 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LTBR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRGAP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AP3D1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADAM3B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PARD3B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TWSG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAAP20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LZTS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TOR2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ST6GALNAC5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NPAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GJC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on